Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00014) | |||||
---|---|---|---|---|---|
Name |
Adefovir dipivoxil
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
ADEFOVIR DIPIVOXIL; 142340-99-6; Hepsera; Preveon; Adefovir pivoxil; bis-POM PMEA; GS 0840; GS-0840; GS 840; GS-840; Adefovir dipivoxyl; [2-(6-aminopurin-9-yl)ethoxymethyl-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate; UNII-U6Q8Z01514; Adefovir dipivoxil (USAN); Adefovir dipivoxil [USAN]; (((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)phosphinylidene)bis(oxymethylene) 2,2-dimethylpropanoate; 9-(2-((Bis((pivaloyloxy)methoxy)phosphinyl)methoxy)ethyl)adenine; Adefovir di(pivaloyloxymethyl) ester; MFCD00869897; Adefovir Dipivoxil (Preveon, Hepsera); U6Q8Z01514; NCGC00164624-01; Adefovirdipivoxl; DSSTox_CID_26487; DSSTox_RID_81658; DSSTox_GSID_46487; 9-[2-[Bis(pivaloyloxymethoxy)phosphorylmethoxy]ethyl]adenine; YouHeDing; [({[2-(6-amino-9H-purin-9-yl)ethoxy]methyl}({[(2,2-dimethylpropanoyl)oxy]methoxy})phosphoryl)oxy]methyl 2,2-dimethylpropanoate; Bis(pom)PMEA; SMR002530072; Hepsera (TM); Hepsera (TN); Piv2PMEA; CAS-142340-99-6; C20H32N5O8P; Bis(POM)-PMEA; Adefovir pivoxil (JAN); 9-(2-((-Bis((pivaloyloxy)methoxy)phosphinyl)methoxy)ethyl)adenine; PubChem14224; CHEMBL922; ((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)phosphonic acid, diester with hydroxymethyl pivalate; SCHEMBL29729; MLS003915635; MLS004774124; Propanoic acid, 2,2-dimethyl-, (((2-(6-amino-9H-purin-9-yl)ethoxy)methyl)phosphinylidene)bis(oxymethylene) ester; ARONIS27063; DTXSID5046487; CHEBI:31175; Bis(pivaloyloxymethyl)-9-(2-phosphonylmethoxyethyl)adenine; BCPP000434; HMS3604F09; HMS3655I04; BCP22959; HY-B0255; ZINC3930376; Tox21_112243; ANW-43238; BDBM50248359; CA0117; STL257088; AKOS005145737; Tox21_112243_1; AB07592; AC-1693; BCP9000232; CCG-269700; DB00718; GS-3604; MCULE-6257358029; NCGC00164624-02; NCGC00164624-03; NCGC00164624-11; ((((2-(6-amino-9H-purin-9-yl)ethoxy)methyl)phosphoryl)bis(oxy))bis(methylene) bis(2,2-dimethylpropanoate); AK546547; BCP0726000157; AB0012816; FT-0631164; SW219933-1; D01655; W-2203; AB01274706-01; AB01274706_02; 340A996; A807894; Adefovir dipivoxil 100 microg/mL in Acetonitrile; SR-01000931258; Q-101927; SR-01000931258-2; BRD-K96159438-001-03-0; 9-(2[bis(Pivaloyloxymethoxy)phosphorylmethoxy]ethyl)adenine; Adefovir dipivoxil, Antibiotic for Culture Media Use Only; BIS(PIVALOYLOXYMETHYL)-9-[2-(PHOSPHONOMETHOXY)ETHYL]ADENINE; ((((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)phosphoryl)-bis(oxy))bis(methylene) bis(2,2-dimethylpropanoate); (((2-(6-AMINO-9H-PURIN-9-YL)ETHOXY)METHYL)PHOSPHORYL)BIS(OXY)BIS(METHYLENE) BIS(2,2-DIMETHYLPROPANOATE); ({[2-(6-amino-9H-purin-9-yl)ethoxy]methyl}phosphoryl)bis(oxymethanediyl) bis(2,2-dimethylpropanoate); 2,2-dimethylpropanoic acid [2-(6-aminopurin-9-yl)ethoxymethyl-[(2,2-dimethyl-1-oxopropoxy)methoxy]phosphoryl]oxymethyl ester; 3-{[2-(6-amino-9H-purin-9-yl)ethoxy]methyl}-8,8-dimethyl-3-oxido-7-oxo-2,4,6-trioxa-3?5-phosphanon-1-yl 2,2-dimethylpropanoate; 3-{[2-(6-amino-9H-purin-9-yl)ethoxy]methyl}-8,8-dimethyl-3-oxido-7-oxo-2,4,6-trioxa-3lambda~5~-phosphanon-1-yl 2,2-dimethylpropanoate
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Viral hepatitis | ICD-11: 1E51 | [1] | ||
PubChem CID | |||||
Formula |
C20H32N5O8P
|
||||
Canonical SMILES |
CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C
|
||||
InChI |
1S/C20H32N5O8P/c1-19(2,3)17(26)30-11-32-34(28,33-12-31-18(27)20(4,5)6)13-29-8-7-25-10-24-14-15(21)22-9-23-16(14)25/h9-10H,7-8,11-13H2,1-6H3,(H2,21,22,23)
|
||||
InChIKey |
WOZSCQDILHKSGG-UHFFFAOYSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=60871"></iframe>
|
||||
3D MOL | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 501.5 | Topological Polar Surface Area | 167 | |
XlogP | 1.8 | Complexity | 706 | ||
Heavy Atom Count | 34 | Rotatable Bond Count | 15 | ||
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 12 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Adefovir dipivoxil 10 mg tablet | Click to Show/Hide the Full List of Formulation(s): 2 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; Magnesium stearate; Crospovidone; Silicon dioxide; Cellulose, microcrystalline; Copovidone
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Sigmapharm Laboratories | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [2] | |||
Crospovidone | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [2] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [2] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Magnesium stearate; Talc; Water; Croscarmellose sodium; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Gilead Sciences | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [2] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [2] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.